Buy Myhep All : Velpatasvir & Sofosbuvir Tablets 28’S Online

$131.62

Brand Name : Myhep All
Composition : Velpatasvir & Sofosbuvir
Manufactured by : Mylan Pharmaceutical Pvt. Ltd.
Strength : Velpatasvir 100 mg and Sofosbuvir 400 mg
Form : Tablets
Packing : Pack of 28 Tablets

Prescription Required *

- +
Compare
SKU: 787726 Category:

Description

Description:

Myhep All is a combination medication used in the treatment of chronic hepatitis C virus (HCV) infection. Each pack contains 28 tablets, with each tablet containing a combination of velpatasvir (100 mg) and sofosbuvir (400 mg).

Indications:

Myhep All is indicated for the treatment of chronic hepatitis C virus (HCV) infection in adults. It is used to treat HCV genotypes 1, 2, 3, 4, 5, or 6 in patients with or without compensated cirrhosis.

Mechanism of Action:

  • Velpatasvir: Velpatasvir is an inhibitor of the HCV NS5A protein. It works by interfering with the replication of the hepatitis C virus and inhibiting the viral RNA replication process.
  • Sofosbuvir: Sofosbuvir is a nucleotide analog inhibitor of the HCV NS5B polymerase. It acts by blocking the enzyme involved in viral replication, thereby preventing the hepatitis C virus from multiplying and reducing the viral load in the body.

Administration:

Myhep All tablets are taken orally with or without food. The usual dosage regimen is one tablet taken once daily. The tablets should be swallowed whole with a glass of water and should not be crushed, chewed, or broken.

Dosage:

The recommended dosage of Myhep All is one tablet (100 mg velpatasvir + 400 mg sofosbuvir) taken orally once daily for a duration specified by a healthcare provider. The duration of treatment may vary depending on factors such as HCV genotype, liver condition, and previous treatment history.

Side Effects:

Common side effects of Myhep All may include:

  • Headache
  • Fatigue
  • Nausea
  • Diarrhea
  • Insomnia
  • Rash
  • Decreased appetite
  • Muscle or joint pain

Contraindications:

Myhep All is contraindicated in patients with a known hypersensitivity to velpatasvir, sofosbuvir, or any other components of the formulation. It should not be used in patients with severe renal impairment (creatinine clearance less than 30 mL/min) or severe hepatic impairment (Child-Pugh class C).

Storage:

Myhep All should be stored at room temperature (20°C to 25°C) in its original packaging, protected from light and moisture. Keep out of reach of children and pets.

Prescription Required:

Myhep All is a prescription medication, and its use should be supervised by a qualified healthcare professional.

Note:

This description provides general information about Myhep All and should not be used as a substitute for professional medical advice. Always consult a healthcare professional for guidance on the appropriate use, dosage, and potential risks and benefits of Myhep All in your specific situation.